Literature DB >> 26643816

Psoriasis and uric acid: a population-based cross-sectional study.

Y C Lai1, Y W Yew2.   

Abstract

BACKGROUND: Psoriasis has been reported to be associated with raised serum uric acid levels and gout, and uric acid has been demonstrated to mediate inflammatory pathways via secretion of pro-inflammatory chemokines. AIM: To evaluate the association between psoriasis, serum uric acid levels and gout in a cross-sectional study using the US National Health and Nutrition Examination Survey (NHANES) database.
METHODS: Data on clinical history of psoriasis, gout and other relevant medical conditions from the questionnaire as well as laboratory parameters for serum uric acid and lipid levels in the periods 2003-2006 and 2011-2012 were analysed. Multivariate analysis with logistic regression modelling was performed, with hyperuricaemia as the dependent variable, and age, sex, ethnicity, body mass index, metabolic syndrome, current smoking status, alcohol consumption and history of psoriasis as the independent variables.
RESULTS: Of the 11 282 study participants, 297 (2.6%) reported a history of psoriasis and 1493 (13.2%) were found to have hyperuricaemia. Patients with psoriasis were at increased risk of having hyperuricaemia, compared with those without psoriasis (OR = 1.37; P = 0.04). They were also more likely to report a history of gout (OR = 1.83; P < 0.05). However, neither association was significant after adjusting for potential confounders with multivariate logistic regression.
CONCLUSION: In conclusion, there was insufficient evidence to show that psoriasis is an independent risk factor of hyperuricaemia or gout. A raised serum uric acid level may be a consequence of metabolic syndrome, which in turn is associated with psoriasis.
© 2015 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26643816     DOI: 10.1111/ced.12781

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  7 in total

1.  Bone microstructure and volumetric bone mineral density in patients with hyperuricemia with and without psoriasis.

Authors:  D Simon; J Haschka; C Muschitz; A Kocijan; A Baierl; A Kleyer; G Schett; S Kapiotis; H Resch; M Sticherling; J Rech; R Kocijan
Journal:  Osteoporos Int       Date:  2020-01-10       Impact factor: 4.507

2.  Assessment of Crystals in the Synovial Fluid of Psoriatic Arthritis Patients in Relation to Disease Activity.

Authors:  Mariela Geneva-Popova; Stanislava Popova-Belova; Velicka Popova; Nikolay Stoilov
Journal:  Diagnostics (Basel)       Date:  2022-05-18

3.  Systemic abnormalities of psoriatic patients: a retrospective study.

Authors:  Li Yin; Jia-Li Xu; Ying-Ying Hu; Andrew Johnston; Zhi-Qiang Yin
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-11-10

4.  An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies.

Authors:  Sanminder Singh; Paulina Young; April W Armstrong
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

5.  Serum uric acid levels and hyperuricemia in patients with psoriasis: a hospital-based cross-sectional study.

Authors:  Xin-Yu Gui; Hong-Zhong Jin; Zhen-Jie Wang; Teng-Da Xu
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

6.  The association of serum uric acid levels in psoriasis patients: A systematic review and network meta-analysis.

Authors:  Yuan Yuan; Ming Liu; WenHong Liu; Hua Du
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Paraoxonase-1 and other factors related to oxidative stress in psoriasis.

Authors:  Magdalena Oszukowska; Magdalena Kozłowska; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2020-03-09       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.